Rising Incidence of Bone Disorders will Propel the Global Market for Osteoporosis Drugs

List of Tables

Osteoporosis Drugs Market: Scope of the Report

The latest publication by Persistence Market Research on the global osteoporosis drugs market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for osteoporosis drugs and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the osteoporosis drugs market. Shareholders in the osteoporosis drugs market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the osteoporosis drugs market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the osteoporosis drugs market offers information divided into three important segments - drugs, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

Bisphosphonates

Parathyroid Hormone Therapy Drugs

Calcitonin

Selective Estrogen Receptors Modulators (SERMs)

RANK Ligand Inhibitors

Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Sales

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for osteoporosis drugs over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the osteoporosis drugs market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the osteoporosis drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the osteoporosis drugs market are more accurate and reliable.

Product Code: PMRREP2983

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends

4. Key Success Factors

4.1. Drug Adoption Analysis
4.2. Key Regulations
4.3. Recent Drug launches/ Approvals
4.4. Pipeline Assessment
4.5. PESTEL Analysis
4.6. Value Chain Analysis
4.7. Key Promotional Strategies, By Key Players

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Orthopedic Drugs & Devices market outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increase in R&D Spending
- 5.2.2. Growing Osteoarthritis Prevalence
- 5.2.3. Cost of Drug
- 5.2.4. Drug Features
- 5.2.5. New Drug Pipeline
- 5.2.6. Changes in Regulatory Policies
- 5.2.7. Strategic Collaborations amongst Players
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Drug
- 6.1.2. By Distribution Channel
- 6.1.3. By Country
6.2. 2022 Market Scenario

7. Global Osteoporosis Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033, By Drug

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2016-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2023-2033
- 8.3.1. Bisphosphonates
- 8.3.2. Parathyroid Hormone Therapy Drugs
- 8.3.3. Calcitonin
- 8.3.4. Selective Estrogen Receptors Modulators (SERMs)
- 8.3.5. RANK Ligand Inhibitors
8.4. Market Attractiveness Analysis By Drug

9. Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2016-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
- 9.3.1. Retail Pharmacies
- 9.3.2. Hospital Pharmacies
- 9.3.3. Online Sales
9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033, By Region

10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region 2023-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. East Asia
- 10.3.5. South Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Drug
- 11.3.3. By Distribution Channel
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Drug
- 11.4.3. By Distribution Channel
11.5. Market Trends
11.6. Drivers and Restraints - Impact Analysis
11.7. Key Players - Intensity Mapping
11.8. Country Level Analysis & Forecast
- 11.8.1. U.S. Osteoporosis Drugs Market Analysis
  - 11.8.1.1. Introduction
  - 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.1.2.1. By Drug
    - 11.8.1.2.2. By Distribution Channel
- 11.8.2. Canada Osteoporosis Drugs Market Analysis
  - 11.8.2.1. Introduction
  - 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.2.2.1. By Drug
    - 11.8.2.2.2. By Distribution Channel

12. Latin America Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 12.3.1. By Country
  - 12.3.1.1. Mexico
  - 12.3.1.2. Brazil
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Drug
- 12.3.3. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Drug
- 12.4.3. By Distribution Channel
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Key Players - Intensity Mapping
12.8. Country Level Analysis & Forecast
- 12.8.1. Mexico Osteoporosis Drugs Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Drug
    - 12.8.1.2.2. By Distribution Channel
- 12.8.2. Brazil Osteoporosis Drugs Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Drug
    - 12.8.2.2.2. By Distribution Channel
- 12.8.3. Argentina Osteoporosis Drugs Market Analysis
  - 12.8.3.1. Introduction
  - 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.3.2.1. By Drug
    - 12.8.3.2.2. By Distribution Channel

13. Europe Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. Italy
  - 13.3.1.3. France
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. BENELUX
  - 13.3.1.7. Russia
  - 13.3.1.8. Rest of Europe
- 13.3.2. By Drug
- 13.3.3. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Drug
- 13.4.3. By Distribution Channel
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Players - Intensity Mapping
13.8. Country Level Analysis & Forecast
- 13.8.1. Germany Osteoporosis Drugs Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Drug
    - 13.8.1.2.2. By Distribution Channel
- 13.8.2. Italy Osteoporosis Drugs Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Drug
    - 13.8.2.2.2. By Distribution Channel
- 13.8.3. France Osteoporosis Drugs Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Drug
    - 13.8.3.2.2. By Distribution Channel
- 13.8.4. U.K. Osteoporosis Drugs Market Analysis
  - 13.8.4.1. Introduction
  - 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.4.2.1. By Drug
    - 13.8.4.2.2. By Distribution Channel
- 13.8.5. Spain Osteoporosis Drugs Market Analysis
  - 13.8.5.1. Introduction
  - 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.5.2.1. By Drug
    - 13.8.5.2.2. By Distribution Channel
- 13.8.6. BENELUX Osteoporosis Drugs Market Analysis
  - 13.8.6.1. Introduction
  - 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.6.2.1. By Drug
    - 13.8.6.2.2. By Distribution Channel
- 13.8.7. Russia Osteoporosis Drugs Market Analysis
  - 13.8.7.1. Introduction
  - 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.7.2.1. By Drug
    - 13.8.7.2.2. By Distribution Channel

14. East Asia Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 14.3.1. By Country
  - 14.3.1.1. China
  - 14.3.1.2. Japan
  - 14.3.1.3. South Korea
- 14.3.2. By Drug
- 14.3.3. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Drug
- 14.4.3. By Distribution Channel
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
- 14.8.1. China Osteoporosis Drugs Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Drug
    - 14.8.1.2.2. By Distribution Channel
- 14.8.2. Japan Osteoporosis Drugs Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Drug
    - 14.8.2.2.2. By Distribution Channel
- 14.8.3. South Korea Osteoporosis Drugs Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Drug
    - 14.8.3.2.2. By Distribution Channel

15. South Asia Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Indonesia
  - 15.3.1.3. Malaysia
  - 15.3.1.4. Thailand
  - 15.3.1.5. Rest of South Asia
- 15.3.2. By Drug
- 15.3.3. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Drug
- 15.4.3. By Distribution Channel
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
- 15.8.1. India Osteoporosis Drugs Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Drug
    - 15.8.1.2.2. By Distribution Channel
- 15.8.2. Indonesia Osteoporosis Drugs Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Drug
    - 15.8.2.2.2. By Distribution Channel
- 15.8.3. Malaysia Osteoporosis Drugs Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Drug
    - 15.8.3.2.2. By Distribution Channel
- 15.8.4. Thailand Osteoporosis Drugs Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Drug
    - 15.8.4.2.2. By Distribution Channel

16. Oceania Osteoporosis Drugs Market 2016-2023 and Forecast 2023-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Drug
- 16.3.3. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Drug
- 16.4.3. By Distribution Channel
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
- 16.8.1. Australia Osteoporosis Drugs Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Drug
    - 16.8.1.2.2. By Distribution Channel
- 16.8.2. New Zealand Osteoporosis Drugs Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Drug
    - 16.8.2.2.2. By Distribution Channel

17. Middle East and Africa (MEA) Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkey
  - 17.3.1.3. North Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Drug
- 17.3.3. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Drug
- 17.4.3. By Distribution Channel
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
- 17.8.1. GCC Countries Osteoporosis Drugs Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Drug
    - 17.8.1.2.2. By Distribution Channel
- 17.8.2. Turkey Osteoporosis Drugs Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Drug
    - 17.8.2.2.2. By Distribution Channel
- 17.8.3. South Africa Osteoporosis Drugs Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Drug
    - 17.8.3.2.2. By Distribution Channel
- 17.8.4. North Africa Osteoporosis Drugs Market Analysis
  - 17.8.4.1. Introduction
  - 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.4.2.1. By Drug
    - 17.8.4.2.2. By Distribution Channel

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Deep Dive
- 19.2.1. Eli Lilly and Company
  - 19.2.1.1. Overview
  - 19.2.1.2. Product Portfolio
  - 19.2.1.3. Sales Footprint
  - 19.2.1.4. Key Financials
  - 19.2.1.5. SWOT Analysis
  - 19.2.1.6. Strategy Overview
    - 19.2.1.6.1. Marketing Strategy
    - 19.2.1.6.2. Product Strategy
    - 19.2.1.6.3. Channel Strategy
- 19.2.2. F. Hoffmann-La Roche Ltd.
  - 19.2.2.1. Overview
  - 19.2.2.2. Product Portfolio
  - 19.2.2.3. Sales Footprint
  - 19.2.2.4. Key Financials
  - 19.2.2.5. SWOT Analysis
  - 19.2.2.6. Strategy Overview
    - 19.2.2.6.1. Marketing Strategy
    - 19.2.2.6.2. Product Strategy
    - 19.2.2.6.3. Channel Strategy
- 19.2.3. Merck & Co, Inc.
  - 19.2.3.1. Overview
  - 19.2.3.2. Product Portfolio
  - 19.2.3.3. Sales Footprint
  - 19.2.3.4. Key Financials
  - 19.2.3.5. SWOT Analysis
  - 19.2.3.6. Strategy Overview
    - 19.2.3.6.1. Marketing Strategy
    - 19.2.3.6.2. Product Strategy
    - 19.2.3.6.3. Channel Strategy
- 19.2.4. Novartis AG
  - 19.2.4.1. Overview
  - 19.2.4.2. Product Portfolio
  - 19.2.4.3. Sales Footprint
  - 19.2.4.4. Key Financials
  - 19.2.4.5. SWOT Analysis
  - 19.2.4.6. Strategy Overview
    - 19.2.4.6.1. Marketing Strategy
    - 19.2.4.6.2. Product Strategy
    - 19.2.4.6.3. Channel Strategy
- 19.2.5. Amgen, Inc.
  - 19.2.5.1. Overview
  - 19.2.5.2. Product Portfolio
  - 19.2.5.3. Sales Footprint
  - 19.2.5.4. Key Financials
  - 19.2.5.5. SWOT Analysis
  - 19.2.5.6. Strategy Overview
    - 19.2.5.6.1. Marketing Strategy
    - 19.2.5.6.2. Product Strategy
    - 19.2.5.6.3. Channel Strategy
- 19.2.6. Novo Nordisk A/S
  - 19.2.6.1. Overview
  - 19.2.6.2. Product Portfolio
  - 19.2.6.3. Sales Footprint
  - 19.2.6.4. Key Financials
  - 19.2.6.5. SWOT Analysis
  - 19.2.6.6. Strategy Overview
    - 19.2.6.6.1. Marketing Strategy
    - 19.2.6.6.2. Product Strategy
    - 19.2.6.6.3. Channel Strategy
- 19.2.7. Actavis plc
  - 19.2.7.1. Overview
  - 19.2.7.2. Product Portfolio
  - 19.2.7.3. Sales Footprint
  - 19.2.7.4. Key Financials
  - 19.2.7.5. SWOT Analysis
  - 19.2.7.6. Strategy Overview
    - 19.2.7.6.1. Marketing Strategy
    - 19.2.7.6.2. Product Strategy
    - 19.2.7.6.3. Channel Strategy
- 19.2.8. Pfizer, Inc.
  - 19.2.8.1. Overview
  - 19.2.8.2. Product Portfolio
  - 19.2.8.3. Sales Footprint
  - 19.2.8.4. Key Financials
  - 19.2.8.5. SWOT Analysis
  - 19.2.8.6. Strategy Overview
    - 19.2.8.6.1. Marketing Strategy
    - 19.2.8.6.2. Product Strategy
    - 19.2.8.6.3. Channel Strategy
- 19.2.9. GlaxoSmithKline plc
  - 19.2.9.1. Overview
  - 19.2.9.2. Product Portfolio
  - 19.2.9.3. Sales Footprint
  - 19.2.9.4. Key Financials
  - 19.2.9.5. SWOT Analysis
  - 19.2.9.6. Strategy Overview
    - 19.2.9.6.1. Marketing Strategy
    - 19.2.9.6.2. Product Strategy
    - 19.2.9.6.3. Channel Strategy
- 19.2.10. Teva Pharmaceutical Industries Ltd
  - 19.2.10.1. Overview
  - 19.2.10.2. Product Portfolio
  - 19.2.10.3. Sales Footprint
  - 19.2.10.4. Key Financials
  - 19.2.10.5. SWOT Analysis
  - 19.2.10.6. Strategy Overview
    - 19.2.10.6.1. Marketing Strategy
    - 19.2.10.6.2. Product Strategy
    - 19.2.10.6.3. Channel Strategy
- 19.2.11. Enzene Biosciences Ltd
  - 19.2.11.1. Overview
  - 19.2.11.2. Product Portfolio
  - 19.2.11.3. Sales Footprint
  - 19.2.11.4. Key Financials
  - 19.2.11.5. SWOT Analysis
  - 19.2.11.6. Strategy Overview
    - 19.2.11.6.1. Marketing Strategy
    - 19.2.11.6.2. Product Strategy
    - 19.2.11.6.3. Channel Strategy
- 19.2.12. Theramex
  - 19.2.12.1. Overview
  - 19.2.12.2. Product Portfolio
  - 19.2.12.3. Sales Footprint
  - 19.2.12.4. Key Financials
  - 19.2.12.5. SWOT Analysis
  - 19.2.12.6. Strategy Overview
    - 19.2.12.6.1. Marketing Strategy
    - 19.2.12.6.2. Product Strategy
    - 19.2.12.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

Product Code: PMRREP2983

List of Tables

Table 01: Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033 By Drug
Table 02: Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel
Table 03: Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033 by Region
Table 04: North America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 05: North America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Drug
Table 06: North America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Distribution Channel
Table 07: Latin America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 08: Latin America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Drug
Table 09: Latin America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Distribution Channel
Table 10: Europe Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 11: Europe Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Drug
Table 12: Europe Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel
Table 13: East Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 14: East Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Drug
Table 15: East Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Distribution Channel
Table 16: South Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 17: South Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Drug
Table 18: South Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Distribution Channel
Table 19: Oceania Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 20: Oceania Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Drug
Table 21: Oceania Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel
Table 22: Middle East & Africa Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
Table 23: Middle East & Africa Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Drug
Table 24: Middle East & Africa Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel

List of Figures

Figure 01: Global Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 02: Global Osteoporosis Drugs Market Forecast & Y-o-Y Growth 2023-2033
Figure 03: Global Osteoporosis Drugs Market Absolute $ Opportunity (US$ Mn) Analysis 2022-2033
Figure 04: Global Osteoporosis Drugs Market Value Share (%) Analysis 2023 and 2033 By Drug
Figure 05: Global Osteoporosis Drugs Market Y-o-Y Growth (%) Analysis 2022-2033 By Drug
Figure 06: Global Osteoporosis Drugs Market Attractiveness Analysis 2023-2033 By Drug
Figure 07: Global Osteoporosis Drugs Market Value Share (%) Analysis 2023 and 2033 By Distribution Channel
Figure 08: Global Osteoporosis Drugs Market Y-o-Y Growth (%) Analysis 2022-2033 By Distribution Channel
Figure 09: Global Osteoporosis Drugs Market Attractiveness Analysis 2023-2033 By Distribution Channel
Figure 10: Global Osteoporosis Drugs Market Value Share (%) Analysis 2023 and 2033 by Region
Figure 11: Global Osteoporosis Drugs Market Y-o-Y Growth (%) Analysis 2022-2033 by Region
Figure 12: Global Osteoporosis Drugs Market Attractiveness Analysis 2023-2033 by Region
Figure 13: North America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 14: North America Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 15: North America Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 16: North America Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 17: North America Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 18: North America Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 19: North America Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 20: U.S. Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 21: Global Vs. U.S. Growth Comparison 2022 - 2033
Figure 22: U.S. Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 23: U.S. Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 24: Canada Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 25: Global Vs. Canada. Growth Comparison 2022 - 2033
Figure 26: Canada Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 27: Canada Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 28: Latin America Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 29: Latin America Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 30: Latin America Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 31: Latin America Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 32: Latin America Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 33: Latin America Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 34: Latin America Osteoporosis Drugs Market Attractiveness Analysis By Distribution Channel 2023-2033
Figure 35: Latin America Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 36: Mexico Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 37: Global Vs Mexico Growth Comparison 2022 - 2033
Figure 38: Mexico Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 39: Mexico Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 40: Brazil Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 41: Global Vs. Brazil. Growth Comparison 2022 - 2033
Figure 42: Brazil Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 43: Brazil Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 44: Argentina Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 45: Global Vs Argentina Growth Comparison 2022 - 2033
Figure 46: Argentina Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 47: Argentina Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 48: Europe Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 49: Europe Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 50: Europe Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 51: Europe Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 52: Europe Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 53: Europe Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 54: Europe Osteoporosis Drugs Market Attractiveness Analysis By Distribution Channel 2023-2033
Figure 55: Europe Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 56: UK Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 57: Global Vs. UK Growth Comparison 2022 - 2033
Figure 58: UK Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 59: UK Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 60: Germany Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 61: Global Vs. Germany Growth Comparison 2022 - 2033
Figure 62: Germany Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 63: Germany Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 64: Italy Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 65: Global Vs. Italy Growth Comparison 2022 - 2033
Figure 66: Italy Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 67: Italy Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 68: France Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 69: Global Vs France Growth Comparison 2022 - 2033
Figure 70: France Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 71: France Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 72: Spain Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 73: Global Vs Spain Growth Comparison 2022 - 2033
Figure 74: Spain Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 75: Spain Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 76: Russia Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 77: Global Vs Russia Growth Comparison 2022 - 2033
Figure 78: Russia Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 79: Russia Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 80: BENELUX Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 81: Global Vs BENELUX Growth Comparison 2022 - 2033
Figure 82: BENELUX Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 83: BENELUX Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 84: East Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 85: East Asia Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 86: East Asia Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 87: East Asia Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 88: East Asia Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 89: East Asia Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 90: East Asia Osteoporosis Drugs Market Attractiveness Analysis By Distribution Channel 2023-2033
Figure 91: East Asia Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 92: China Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 93: Global Vs. China Growth Comparison 2022 - 2033
Figure 94: China Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 95: China Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 96: Japan Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 97: Global Vs. Japan Growth Comparison 2022 - 2033
Figure 98: Japan Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 99: Japan Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 100: South Korea Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 101: Global Vs South Korea Growth Comparison 2022 - 2033
Figure 102: South Korea Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 103: South Korea Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 104: South Asia Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 105: South Asia Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 106: South Asia Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 107: South Asia Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 108: South Asia Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 109: South Asia Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 110: South Asia Osteoporosis Drugs Market Attractiveness Analysis By Distribution Channel 2023-2033
Figure 111: South Asia Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 112: India Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 113: Global Vs. India Growth Comparison 2022 - 2033
Figure 114: India Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 115: India Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 116: Indonesia Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 117: Global Vs. Indonesia Growth Comparison 2022 - 2033
Figure 118: Indonesia Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 119: Indonesia Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 120: Malaysia Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 121: Global Vs. Malaysia Growth Comparison 2022 - 2033
Figure 122: Malaysia Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 123: Malaysia Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 124: Thailand Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 125: Global Vs. Thailand Growth Comparison 2022 - 2033
Figure 126: Thailand Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 127: Thailand Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 128: Oceania Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 129: Oceania Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 130: Oceania Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 131: Oceania Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 132: Oceania Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 133: Oceania Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 134: Oceania Osteoporosis Drugs Market Attractiveness Analysis By Distribution Channel 2023-2033
Figure 135: Oceania Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 136: Australia Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 137: Global Vs. Australia Growth Comparison 2022 - 2033
Figure 138: Australia Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 139: Australia Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 140: New Zealand Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 141: Global Vs New Zealand Growth Comparison 2022 - 2033
Figure 142: New Zealand Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 143: New Zealand Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 144: Middle East & Africa Osteoporosis Drugs Market Value (US$ Mn) Analysis 2016-2022
Figure 145: Middle East & Africa Osteoporosis Drugs Market Value (US$ Mn) Forecast 2023-2033
Figure 146: Middle East & Africa Osteoporosis Drugs Market Value Share By Drug (2023 E)
Figure 147: Middle East & Africa Osteoporosis Drugs Market Value Share By Distribution Channel (2023 E)
Figure 148: Middle East & Africa Osteoporosis Drugs Market Value Share by Country (2023 E)
Figure 149: Middle East & Africa Osteoporosis Drugs Market Attractiveness Analysis By Drug 2023-2033
Figure 150: Middle East & Africa Osteoporosis Drugs Market Attractiveness Analysis By Distribution Channel 2023-2033
Figure 151: Middle East & Africa Osteoporosis Drugs Market Attractiveness Analysis by Country 2023-2033
Figure 152: GCC Countries Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 153: Global Vs GCC Countries Growth Comparison 2022 - 2033
Figure 154: GCC Countries Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 155: GCC Countries Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 156: Turkey Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 157: Global Vs. Turkey Growth Comparison 2022 - 2033
Figure 158: Turkey Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 159: Turkey Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 160: South Africa Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 161: Global Vs. South Africa Growth Comparison 2022 - 2033
Figure 162: South Africa Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 163: South Africa Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033
Figure 164: North Africa Osteoporosis Drugs Market Value Proportion Analysis 2022
Figure 165: Global Vs North Africa Growth Comparison 2022 - 2033
Figure 166: North Africa Osteoporosis Drugs Market Share Analysis (%) By Drug 2022 & 2033
Figure 167: North Africa Osteoporosis Drugs Market Share Analysis (%) By Distribution Channel 2022 & 2033

Rising Incidence of Bone Disorders will Propel the Global Market for Osteoporosis Drugs

Description

Table of Contents

List of Tables

Key Market Segments

Key Questions Answered in Report:

Research Methodology

Table of Contents

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Success Factors

5. Market Background

6. COVID-19 Crisis Analysis

7. Global Osteoporosis Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

8. Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033, By Drug

9. Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel

10. Global Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033, By Region

11. North America Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

12. Latin America Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

13. Europe Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

14. East Asia Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

15. South Asia Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

16. Oceania Osteoporosis Drugs Market 2016-2023 and Forecast 2023-2033

17. Middle East and Africa (MEA) Osteoporosis Drugs Market Analysis 2016-2022 and Forecast 2023-2033

18. Market Structure Analysis

19. Competition Analysis

20. Assumptions and Acronyms Used

21. Research Methodology

List of Tables

List of Figures